Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Information

Selected financial information for the Company’s operating segments is as follows:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2018     2017     2018     2017  
Net revenues - External                                
Clinical Laboratory Operations   $ 17,568     $ 190,610     $ 177,890     $ 949,440  
Hospital Operations     5,021,541       619,478       9,755,099       619,478  
    $ 5,039,110     $ 810,088     $ 9,932,989     $ 1,568,918  
(Loss) from operations                                
Clinical Laboratory Operations   $ (547,041 )   $ (1,039,118 )   $ (1,765,395 )   $ (3,809,147 )
Hospital Operations     (1,294,580 )     (2,093,805 )     (3,998,943 )     (3,114,473 )
Corporate     (973,954 )     (1,369,765 )     (3,156,645 )     (5,058,569 )
Eliminations     -       -       -       -  
    $ (2,815,575 )   $ (4,502,688 )   $ (8,920,983 )   $ (11,982,189 )
Depreciation and amortization                                
Clinical Laboratory Operations   $ 112,908     $ 410,801     $ 625,877     $ 1,265,174  
Hospital Operations     39,669       15,436       177,386       15,436  
Corporate     248       345       810       1006  
Eliminations     -       -       -       -  
    $ 152,825     $ 426,582     $ 804,073     $ 1,281,616  

 

    September 30, 2018     December 31, 2017  
Total assets                
Clinical Laboratory Operations   $ 421,478     $ 1,503,520  
Supportive Software Solutions     1,650,984       2,549,504  
Decision Support and Informatics     38,323       -  
Hospital Operations     16,730,568       3,436,773  
Corporate     4,087,610       255,566  
Eliminations     (3,506,178 )     (1,454,569 )
Total Assets   $ 19,422,785     $ 6,290,794